Roche Building Alternate-Site Diabetes Testing Capability Via Amira
This article was originally published in The Gray Sheet
Executive Summary
Roche Diagnostics will leverage Amira Medical's alternate-site blood glucose testing technology in order to increase its presence in the integrated spot monitoring (ISM) market